Why the Market Dipped But Eli Lilly (LLY) Gained Today

Stock Performance - Eli Lilly closed at $773 29, marking a +1 07% move from the previous day, outperforming the S&P 500's daily loss of 1 11% [1] - Over the last month, Eli Lilly's shares decreased by 4 79%, surpassing the Medical sector's loss of 6 22% but falling behind the S&P 500's loss of 1 7% [1] Earnings and Revenue Expectations - The company is anticipated to report an EPS of$ 5 48, a 120 08% rise compared to the same quarter of the previous year [2] - Revenue is expected to be $14 06 billion, showing a 50 3% escalation compared to the year-ago quarter [2] Analyst Estimates and Revisions - Recent changes to analyst estimates reflect evolving short-term business trends, with positive revisions indicating a good sign for the company's business outlook [3] - The Zacks Consensus EPS estimate has moved 1 78% higher over the past month [5] Valuation Metrics - Eli Lilly currently trades with a Forward P/E ratio of 31 82, expressing a premium compared to the industry average of 12 34 [6] - The company's PEG ratio is 1 59, higher than the industry average of 1 26 [6] Industry Context - The Large Cap Pharmaceuticals industry, part of the Medical sector, carries a Zacks Industry Rank of 191, placing it within the bottom 24% of over 250 industries [7] - The Zacks Industry Rank shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]